Decreasing Cell Adhesion Between Endothelial Cells to T Cells Through Inhibition of NF-κB Activity

尉建锋,郑树森,徐世国,谢海洋
DOI: https://doi.org/10.3760/cma.j.issn.0254-1785.2005.01.012
2005-01-01
Abstract:Objective To investigate the role of inhibition of nuclear factor kappa B (NF-κB) activation in cell adhesion between T cells to endothelial cells. Methods The pCMV-IκBαM was ~stably transfected into human endothelial cell line ECV304 using geneticin (G418). The pCMV-IκBα was also stably transfected as controls. The NF-κB activity was detected with reporter vector pNF-κB Luciferase and electrophoretic mobility shift assay. The cells with over-expression of non-degraded IκBα protein were selected by Western blot using specific antibody. mRNA levels of cell surface molecules (ICAM-1, VCAM-1) were detected by reverse transcription polymerase chain reaction (RT-PCR). The protein levels of surface adhesion molecules including ICAM-1, VCAM-1 and P-selectin were measured by flow cytometery. The adhesion of Jurkat T cells to ECV304 cells was observed through cell number count using phase-contrast microscopy. Results NF-κB activity was inhibited by over-expression of non-degraded IκBα protein. mRNA levels of adhesion molecules ICAM-1, VCAM-1 were significantly decreased in the cells transfected with pCMV-IκBαM compared to the cells ~transfected with pCMV-IκBα. Flow cytometery revealed that the expression of ICAM-1, VCAM-1 and P-selectin was inhibited significantly. Cell adhesion assay showed pCMV-IκBαM could decrease the ~adhesion of Jurkat T cells to ECV cells from (~71.4 ±~5.2 ) % to (~42.2 ±~3.7 ) % (P~0.05 ) compared to those transfected with pCMV-IκBα. Conclusion The pCMV-IκBαM, which inhibits the activity of NF-κB through over-expression of non-degraded IκBα protein, can inhibit the activation of NF-κB. It may be used for gene therapy in diseases involving NF-κB activation abnormally like organ ~transplantation via decreasing cell adhesion.
What problem does this paper attempt to address?